Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

This article originally appeared here.
Share this content:
Gemigliptin, Metformin Combo Beats Monotherapy in T2DM
Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

TUESDAY, Sept. 20, 2016 (HealthDay News) -- Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 13 in Diabetes, Obesity and Metabolism.

Soo Lim, M.D., Ph.D., from the Seoul National University College of Medicine in South Korea, and colleagues randomized 433 patients with T2DM with a glycosylated hemoglobin (HbA1c) level of 7.5 to 11.0 percent and fasting plasma glucose concentration <270 mg/dL to receive either gemigliptin plus metformin, gemigliptin alone, or metformin alone. The change in HbA1c at 24 weeks was assessed as the primary end point.

The researchers found that from baseline to week 24 the mean changes in HbA1c were −2.06 percent, −1.24 percent, and −1.47 percent, respectively, in the combination, gemigliptin monotherapy, and metformin monotherapy groups, respectively. For between-group differences in HbA1c changes, the 95 percent confidence intervals were −1.02 to −0.63 for the combination group versus the gemigliptin group, and −0.82 to −0.41 for the combination group versus the metformin group. Compared with the monotherapy groups, the percentage of patients in the combination therapy group that reached the target HbA1c level <7 percent (or <6.5 percent) was significantly higher. There were no reports of serious side effects.

"In T2DM patients, the initial combination of gemigliptin and metformin had superior efficacy without safety concerns compared with monotherapy with either drug," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Diagnosis of Infantile Spasms Too Often Delayed

Diagnosis of Infantile Spasms Too Often Delayed

Parents, doctors may not recognize infantile spasms early enough to prevent brain damage

Patient Mortality Up With End-of-Rotation Team Transition

Patient Mortality Up With End-of-Rotation Team Transition

Adherence to national recommendations regarding ideal rotation policies ranged from 6 to 67 percent

Pubic Hair Grooming Tied to Heightened Risk of STIs

Pubic Hair Grooming Tied to Heightened Risk of ...

Researchers find extreme groomers have four-fold risk of contracting sexually transmitted infection

is free, fast, and customized just for you!

Already a member?

Sign In Now »